Inspiringly, inferred from the data associated with MK2 inhibitor IV, we found the inhibitor manifesting remarkable reduction of MM cellular growth, colony formation and ABC transporter drug pump (Figure 3). The gene discussed is ABCG2; the disease is Miyoshi myopathy.